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ABSTRACT
Projections of glutamatergic somatosensory and auditory fibers to the cochlear nucleus
(CN) are mostly nonoverlapping: projections from the spinal trigeminal nucleus (Sp5) termi-
nate primarily in the granule cell domains (GCD) of CN, whereas type I auditory nerve fibers
(ANFs) project to the magnocellular areas of the VCN (VCNm) and deep layers of Dorsal CN
(DCN). Vesicular glutamate transporters (VGLUTs), which selectively package glutamate
into synaptic vesicles, have different isoforms associated with distinct subtypes of excitatory
glutamatergic neurons. Here we examined the distributions of VGLUT1 and VGLU2 expres-
sion in the CN and their colocalization with Sp5 and ANF terminals following injections of
anterograde tracers into Sp5 and the cochlea in the guinea pig. The CN regions that showed
the most intense expression of VGLUT1 and VGLUT2 were largely nonoverlapping and were
consistent with ANF and Sp5 projections, respectively: VGLUT1 was highly expressed in
VCNm and the molecular layer of the DCN, whereas VGLUT2 was expressed predominantly
in the GCD. Half (47%  3%) of the Sp5 mossy fiber endings colabeled with VGLUT2, but few
(2.5%  1%) colabeled with VGLUT1. In contrast, ANFs colabeled predominantly with
VGLUT1. The pathway-specific expression of VGLUT isoforms in the CN may be associated
with the intrinsic synaptic properties that are unique to each sensory pathway. J. Comp.
Neurol. 500:777–787, 2007. © 2006 Wiley-Liss, Inc.
Indexing terms: glutamatergic; multisensory integration; plasticity; auditory; cochlear nucleus;
trigeminal
Projections from the trigeminal sensory complex to the
cochlear nucleus (CN; Haenggeli et al., 2005; Zhou and
Shore, 2004) are integrated with auditory inputs from the
cochlea (Shore, 2005). Synaptic terminals of fibers from
the spinal trigeminal nuclei (Sp5) and trigeminal ganglion
are mostly confined to the granule cell domain (GCD) of
the CN. The GCD includes both the superficial shell re-
gion of the ventral CN (VCN) and the fusiform cell layer of
dorsal cochlear nucleus (DCN) and contains numerous
small cells, including granule cells (Weedman et al., 1996;
Zhou and Shore, 2004). The Sp5 projection gives rise to
small boutons and large, irregular swellings (i.e., mossy
fibers; MFs) that make contacts with granule cells
(Haenggeli et al., 2005; Zhou and Shore, 2004). Together
with other somatosensory pathways to the CN, the Sp5
projection conveys proprioceptive information related to
head/neck position and vocal tract gestures that are nec-
essary for facilitating sound localization and attenuating
body-generated sounds (Kanold and Young, 2001; Shore,
2005; Shore and Zhou, 2006). Somatosensory projections
to CN have also been linked to tinnitus by the observa-
tions that tinnitus patients can modulate their tinnitus
with head and neck manipulations (Levine, 1999).
Identification of neurotransmitters associated with tri-
geminal projections to CN is necessary for a better under-
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standing of multisensory integration in the CN. Earlier
studies demonstrated that MFs in the CN originating in
the cuneate nucleus contain round synaptic vesicles, make
asymmetric synapses with postsynaptic targets, and are
labeled with an antibody to glutamate, suggestive of a
glutamatergic pathway (Wright and Ryugo, 1996). MFs
from other sources, such as the pontine nucleus, have
similar ultrastructural characteristics (Ohlrogge et al.,
2001; Weedman et al., 1996). The evidence presented in
this paper suggests that the Sp5 pathway to the CN is also
glutamatergic.
Vesicular glutamate transporters (VGLUTs) selectively
package glutamate into synaptic vesicles and mediate glu-
tamate transport. VGLUTs therefore serve as excellent
markers of glutamatergic neurons. Three subtypes,
VGLUT1, VGLUT2, and VGLUT3, have been identified in
the central nervous system. Although they are structur-
ally homologous and accumulate glutamate with similar
transport kinetics (Fremeau et al., 2002; Gras et al., 2002;
Takamori et al., 2001), their distributions in the brain are
distinct. Both VGLUT1 and VGLUT2 are abundantly ex-
pressed in the brain and account for the majority of known
glutamatergic neurons in the central nervous system,
whereas VGLUT3 is restricted to small, often nongluta-
matergic populations of neurons in the brain. Further-
more, VGLUT1 and VGLUT2 show mutually exclusive
distributions in the adult mammalian brain: VGLUT1 is
intensely expressed in the cerebral and cerebellar cortices
and hippocampus, whereas VGLUT2 is expressed predom-
inantly in the thalamus, deep cerebellar nuclei, and many
brainstem regions (Fremeau et al., 2001; Herzog et al.,
2001; Kaneko et al., 2002; Takamori et al., 2001).
Both VGLUT1 and VGLUT2 (Herzog et al., 2004;
Kaneko et al., 2002), but not VGLUT3, are expressed in
the CN in the adult rodent (Herzog et al., 2004). The two
VGLUT isoforms show little overlapping expression in the
CN: VGLUT1 is more intense in the core region of VCN,
whereas VGLUT2 expression is stronger in the shell re-
gions of VCN (Kaneko et al., 2002). Since the GCD is the
major recipient of Sp5 and other somatosensory inputs
(Haenggeli et al., 2005; Zhou and Shore, 2004), this sug-
gests the association of VGLUT2 with nonauditory inputs
to the CN. In contrast, the core region of CN receives input
from glutamatergic type I auditory nerve fibers (ANFs;
Altschuler et al., 1984; Brown and Ledwith, 1990; Liber-
man, 1993; Martin, 1985; Schweitzer et al., 1991). It is
thus likely that type I ANFs use VGLUT1 to mediate the
glutamate transport. In the present study, our primary
goal was to identify whether glutamate is associated with
trigeminal projections to CN. Concurrently, we examined
the differential distributions of VGLUT2 and VGLUT1
expression in the CN and their association with the Sp5
and ANF projections to the CN. Differential association of
VGLUT isotypes with Sp5 and ANF projections to the CN
demonstrated in this study warrant further investigation
of other nonauditory afferents to the CN.
MATERIALS AND METHODS
Animal preparation
The experiments were performed on 12 pigmented guinea
pigs, weighing 300–400 g. All procedures were performed in
accordance with the NIH guidelines for the use and care of
laboratory animals (NIH publication No. 80-23) and guide-
lines provided by the University Committee on Use and Care
of Animals (UCUCA) of University of Michigan.
Four animals were used for studying VGLUT immuno-
reactivity (VGLUT-ir) in the CN. The animals were eutha-
nized with Nembutal (15 mg/kg, i.p.) and transcardially
perfused with 0.1 M phosphate-buffered saline (PBS), fol-
lowed by 4% paraformaldehyde in PBS. After perfusion-
fixation, the brain was isolated and placed in the same
fixative for 2 hours at 4°C. The brain was transferred into
30% sucrose in 0.1 M PBS overnight at 4°C, and the
brainstem was then sectioned on a freezing microtome at
a thickness of 40 m.
Eight guinea pigs were used in a double-labeling fluo-
rescence study to identify the colocalization of VGLUT1-ir
and VGLUT2-ir with the terminals of Sp5 fibers (n  6)
and ANFs (n  2). These animals were anesthetized with
intramuscular injections of ketamine hydrochloride (Keta-
set; 40 mg/kg) and xylazine (Rompun; 10 mg/kg) and
placed in a stereotaxic frame (David Kopf, Tujunga, CA).
Rectal temperature was maintained at 38°C  0.5°C with
a thermostatically controlled heating pad. The surgical
procedure for injections of anterograde tracers in the Sp5
has been described previously (Zhou and Shore, 2004). A
total volume of 0.1–0.3 l tracer [10% biotinylated
dextran-amine (BDA); MW 10,000: Molecular Probes, Eu-
gene, OR; or Fluoro-Ruby (FR): Molecular Probes] was
sterotaxically pressure-injected into the Sp5 with a
Hamilton microsyringe equipped with a glass micropi-
pette (20 –30 m tip). Tracer injections into the cochlea
[Fluoro-Gold (FG): Fluorochrome, LLC, Denver, CO]
were achieved by making a small hole in the round
window membrane, which was then plugged with a
small, tracer-soaked piece of gelatin sponge (Shore and
Moore, 1998). Four to six days after the injections, animals
were killed, and the brains were processed and sectioned as
described above.
Tissue processing and immunocytochemistry
Sections were mounted in serial order on clean glass
slides and air dried. Alternate serial sections were used to
label VGLUT1 and VGLUT2. All tissue processing was at
room temperature (20–22°C) unless otherwise stated.
Polyclonal antibodies were generated in rabbits against
Strep-Tag fusion protein containing amino acid residues
456–560 of rat VGLUT1 (Synaptic Systems; catalog No.
135 303) and Strep-Tag fusion protein containing amino
acid residues 510–582 of rat VGLUT2 (Synaptic Systems;
catalog No. 135 403). Both primary antibodies and second-
ary antibody (Alexa Fluor 488-conjugated goat anti-rab-
bit; Molecular Probes) were diluted in the same blocking
solution containing 1% normal goat serum (Jackson Im-
Abbreviations
DCN dorsal cochlear nucleus
DCN1 molecular layer of DCN
DCN2 fusiform cell layer of DCN
DCN3 deep layer of DCN
PVCN posteroventral cochlear nucleus
SOC superior olive complex
Sp5 spinal trigeminal nucleus
Sp5C pars caudalis of spinal trigeminal nucleus
Sp5I pars interpolaris of spinal trigeminal nucleus
VCN ventral cochlear nucleus
VCNm magnocellular cell areas of VCN
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munoresearch, West Grove, PA; 005-000-121) in 0.1 M
PBS with 0.1% Triton X-100 (Sigma, St. Louis, MO; 9002-
93-1), pH 7.4. The sections were incubated in the blocking
solution for 30 minutes, followed by overnight incubation
with primary antibodies (1:1,000 for both VGLUT1 and
VGLUT2). After thoroughly rinsing in PBS, sections were
reacted for 2 hours with the secondary antibody. Finally,
sections were rinsed, dehydrated in graded ethanol, and
coverslipped with Micro-cover (Micron, Fairfax, VA). Neg-
ative controls were conducted on sections that were not
treated with either primary or secondary antibodies, re-
sulting in no immunolabeling. Preincubation of VGLUT
antibodies with corresponding synthetic peptides
(Strep-Tag fusion protein containing amino acid resi-
dues 456 –560 of rat VGLUT1, catalog No. 135-3P; and
Strep-Tag fusion protein containing amino acid residues
510 –582 of rat VGLUT2, catalog No. 135-4P; Synaptic
Systems) resulted in negative immunolabeling. VGLUT
expression in the cerebellar cortex had been well docu-
mented (Hioki et al., 2003; Kaneko et al., 2002; Taka-
mori et al., 2001), so cerebellar cortex was used as the
positive control. To visualize BDA-labeled Sp5 termi-
nals colabeled with VGLUT-ir, sections were incubated
for 2 hours with rhodamine red-X conjugated with
streptavidin (S6366; Molecular Probes), followed by im-
munolabeling with VGLUTs.
Western blots
Brain tissue (cerebellum and CN) was collected and
homogenized with a sonicator in an ice-cold lysis buffer
(1% NP40 in PBS) with protease inhibitors (Roche Molec-
ular Biochemicals, Indianapolis, IN). The homogenate was
centrifuged for 5 minutes at 14,000 rpm, and total protein
concentration was measured with the Bio-Rad Protein
Assay (Bio-Rad, Hercules, CA). Equal concentrations of
protein (25 g per lane) were separated by SDS-PAGE and
transferred to a nitrocellulose membrane. After blocking
with PBS-Tween 20 containing 5% nonfat dry milk, im-
munoblotting with primary antibodies was performed (1:
3,000 for both anti-VGLUT1 and anti-VGLUT2); second-
ary antibodies (anti-rabbit-HRP from Sigma) were diluted
at 1:10,000 in PBS-Tween 20 with 5% milk. Signals were
then revealed with ECL (Amersham Pharmacia Biotech,
Arlington Heights, IL) and exposed to Hyperfilm (Amer-
sham Pharmacia Biotech).
Fig. 1. Expression of VGLUT1 and VGLUT2 in the CN. A: West-
ern blot analysis of proteins from CN and cerebellum (CB) with
anti-VGLUT1 and anti-VGLUT2 antibodies. Anti-VGLUT1 antibody
recognized a single band at 60 kDa, and anti-VGLUT2 antibody
recognized a single band at 65 kDa, corresponding to the molecular
weights predicted for VGLUT1 and VGLUT2, respectively. Molecular
weight standards are indicated at left (kDa). B: VGLUT1-ir and
VGLUT2-ir in the cerebellar cortex, as the positive control (M, molec-
ular layer; P, Purkinje cell layer; G, granular layer). C: VGLUT1-ir in
the CN at low magnification (10). VGLUT1 is intensely expressed in
DCN1 and VCNm; weak to moderate VGLUT1-ir is found in the shell
and DCN2; weak VGLUT1-ir is seen in DCN3. D: VGLUT2-ir in the
CN at low magnification (10). VGLUT2 is expressed predominantly
in the shell; moderate VGLUT2-ir is found in DCN2; very weak to
weak staining is found in DCN1, VCNm, and DCN3. Scale bars  50
m in B; 0.5 mm in C,D.
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Image processing and confocal laser
microscopy
Sections were examined with a fluorescent microscope
equipped with the appropriate filters for rhodamine and
Alexa fluor 488 (Leica, DM). Photomicrographs of immu-
nolabeling were digitized and imported to Metamorph for
quantification of immunolabeling. The parameters for dig-
itizing photomicrographs were determined in a pilot study
with optimal contrast between labeling and background
and were then kept constant across conditions and ani-
mals. Photomicrographs were imported into Adobe Photo-
shop for contrast adjustment.
Analysis of VGLUT-ir was conducted for all subdivi-
sions of the CN, with emphasis on the following regions:
the DCN molecular layer (DCN1), the fusiform cell layer
(DCN2), the deep DCN (DCN3), the VCN magnocellular
areas (VCNm), and the shell region of VCN. In the double-
labeling study, alternate serial sections were used to label
VGLUT1 and VGLUT2, respectively. Under epifluores-
cence, the labeled Sp5 terminals were manually counted
on alternate sections in each group. Double labeling of Sp5
terminals with VGLUT-ir was determined by frequently
switching the filters and adjusting the focusing of the
objective lens. Colocalization was established when the
two different labels (VGLUT and Sp5) exactly marked the
same profile at the same focusing level. The number of
terminal counts was multiplied by 4 to achieve the total
terminal counts and corrected for double-counting errors
Fig. 2. Photomicrographs of VGLUT1-ir and VGLUT2-ir in the CN
at higher magnifications (20: A–C,F–H; 40: D,E,I,J). A–E: Differ-
ent forms of VGLUT1 labeling in CN subdivisions: small, densely
distributed granules in DCN1 (A); small to medium-sized granules in
DCN3 (B) and other CN subdivisions (C–E); large irregular granules
in DCN2 (A) and shell (C); endbulb-like structures around large
somata in the VCNm (D,E). F–J: Different forms of VGLUT2 labeling
in CN subdivisions: large, irregular granules in the DCN2 (F) and
shell (H); small to medium-sized granules in DCN3 (G) and VCNm
(I,J). The large irregular VGLUT2-labeled granules in the shell ap-
peared larger and more intense than the VGLUT1-labeled granules in
the same CN region (H). Scale bars  50 m in A,B,D–G,I,J; 100 m
in C,H.
The Journal of Comparative Neurology. DOI 10.1002/cne
780 J. ZHOU ET AL.
by using Abercrombie’s correction: corrected number 
count  [section thickness/(section thickness  terminal
size)] (Abercrombie, 1946). The labeled Sp5 terminal end-
ings were classified as: 1) MF-like terminal endings: large
irregular swellings (2 m), which usually give rise to
collaterals; 2) small boutons: small and round or oval (2
m), including en passant and terminal boutons (Zhou
and Shore, 2004).
In some cases, double-labeled immunofluorescent termi-
nals were also identified by confocal laser microscopy
(Zeiss LSM 510). The images immunolabeled with Alexa
488 and rhodamine were scanned with lasers of argon and
HeNe1, respectively. The images immunolableled with FG
were scanned with a UV laser with an excitation wave-
length of 364 nm, filtered using an emission LP filter at
560 nm, and viewed on the red channel. Images were
acquired at a 1-m optical thickness. To obtain a clear
view of terminal profiles, a series of six to 11 serial optical
sections was obtained to generate a Z-projection of stacks.
The double-labeled ANF terminals were counted manu-
ally from photomicrographs of confocal images (63) of
1-m optical thickness. Two sections were selected from
both the DCN3 and the VCNm. The labeled ANF terminal
endings were classified as 1) endbulb-like terminals, a
group of puncta aligned in a circle or semicircle around a
large cell body, or 2) bead-like terminals, small and round
or oval (2 m), including en passant and terminal bou-
tons. Puncta that were yellow on the confocal multichan-
nel images indicated colocalization.
Quantification and statistical analysis
To quantify VGLUT-ir in the CN, three sections were
selected from each of the following regions: the DCN,
magnocellular VCN, and shell region. For each of these
regions, sections spanned evenly from rostral to caudal
(i.e., one section from the 25th percentile, one from the
median, and one from the 75th percentile). For VCN and
shell region, two pictures (40) were taken of each se-
lected section. For DCN, layers 1, 2, and 3 were photo-
graphed separately, yielding a total of six photomicro-
graphs (40) for each chosen DCN section. In addition,
two pictures with higher magnification (63) were taken
of DCN1 at each selected level for the purpose of manual
counting (see below). Quantification for each region (DCN,
VCN, and shell region) was based on three sections/
regions in each animal. The photomicrographs were then
transferred to Metamorph for quantification. The number
of puncta and the pixel intensity of VGLUT-ir were semi-
automatically measured: To ensure that puncta were
counted reliably, visual inspections and manual correc-
tions were always conducted after each automated count-
ing. Because of the high density of VGLUT1-ir in DCN1,
VGLUT-labeled puncta (VGLUT1 and 2) were counted
manually in a chosen area by using photomicrographs
with higher magnification (63). The number of VGLUT-
labeled puncta was divided by the chosen area to yield the
puncta density.
For quantitative assessment of intensity of VGLUT ex-
pression, the overall pixel value of VGLUT-ir for each
photomicrograph was first corrected by subtracting the
overall pixel value for a negative control section (i.e., with-
out primary antibodies). The corrected value was then
divided by the chosen area of counting, yielding the inten-
sity per unit area (i.e., density of VGLUT expression ex-
pressed as pixel value/mm2). Pixel densities less than 1 
106 pixel value/mm2 were defined as very weak, 1–2  106
pixel value/mm2 as weak, 2–4  106 pixel value/mm2 as
moderate, and 4  106 pixel value/mm2 as intense.
Means and SEMs were calculated for the following: 1)
puncta density of VGLUT1- and VGLUT2-ir, 2) density of
VGLUT expression, 3) number of Sp5-labeled terminals, 4)
number of Sp5-labeled terminals colabeled with VGLUT1
and VGLUT2, and 5) percentage ratios of Sp5 terminals
colabeled with VGLUT1 and VGLUT2. Student’s paired
t-test was used to perform comparisons between means.
RESULTS
VGLUT expression in the CN
Western blot analysis with anti-VGLUT1 antibody
showed a single band at 60 kDa on protein extracted
from both CN and cerebellum (CB; Fig. 1A), and anti-
VGLUT2 antibody recognized a single band at 65 kDa,
corresponding to the molecular weights predicted for
VGLUT1 and VGLUT2, respectively. Positive controls for
VGLUT-ir in the cerebellar cortex revealed dense, granu-
lar VGLUT1-ir and sparse, beaded VGLUT2-ir in the mo-
lecular layer (M in Fig. 1B), and coarse VGLUT1 and
Fig. 3. Quantification of the VGLUT1-ir and VGLUT2-ir in the CN
(n  4). A: Density of VGLUT expression in the CN. B: Puncta density
of the VGLUT1-ir and VGLUT2-ir in the CN. Error bars represent
SEM. Asterisks indicate significant differences (see text).
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Figure 4
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VGLUT2-ir in the granular layers (G in Fig. 1B), as pre-
viously demonstrated (Kaneko et al., 2002; Nunzi et al.,
2003). The most intense VGLUT1-ir was in the molecular
layer of DCN (Fig. 1C, DCN1) and magnocellular area of
VCN (VCNm, Fig. 1C). Weak to moderate VGLUT1-ir was
observed in the shell region of VCN and DCN2.
VGLUT1-ir in DCN3 was weak or very weak. In contrast,
the most intense VGLUT2-ir was in the shell region (Fig.
1C). VGLUT2-ir was moderate in DCN2 and weak or very
weak in DCN1, DCN3, and VCNm (Fig. 1D).
VGLUT1 labeling was in the form of small granules,
densely distributed in DCN1 (Fig. 2A) and also scattered
in other CN subdivisions (Fig. 2A–E). Large, irregular
granules in DCN2 and shell region (Fig. 2C) or endbulb-
like structures around large somata in VCNm were also
observed (Fig. 2D,E). The small granules in DCN1 and the
endbulb-like structures around large cell bodies in VCNm
were the major types of VGLUT1-labeled endings in the
CN. VGLUT2 labeling, on the other hand, was mainly in
the form of large, irregular granules in DCN2 and shell
region (Fig. 2F–J) that were larger and more intense than
VGLUT1-labeled granules in the same CN region (Fig.
2H). Small to medium-sized VGLUT2-labeled granules
were observed in the DCN2 and DCN3 (Fig. 2F,G), shell
region (Fig. 2H), and VCNm (Fig. 2I,J).
Quantification of VGLUT-ir in CN
VGLUT2-ir was significantly more intense than
VGLUT1-ir in the shell region and DCN2 (Fig. 3A; paired
t-test, P  0.01), whereas VGLUT1-ir was significantly
more intense than VGLUT2-ir in the VCNm and DCN1
(Fig. 3A; paired t-test, P  0.001). Similarly, the puncta
density of VGLUT2-labeled granules was significantly
greater than that of VGLUT1-labeled granules in the shell
region and DCN2 (Fig. 3B; paired t-test, P  0.05), whereas
the puncta density of VGLUT1-labeled granules was signif-
icantly greater than that of VGLUT2-labeled granules in the
VCNm and DCN1 (Fig. 3B; paired t-test, P  0.01).
Sp5 terminals colabel with VGLUT2
Six animals were injected with anterograde tracers in
the ipsilateral Sp5 (Sp5I, pars interpolaris). Data analysis
focused on two animals in which the injections were lim-
ited to Sp5I, without diffusion to adjacent areas. In the
other four animals, some spread to the adjacent inferior
cerebellar peduncle (icp) and the lateral medullar reticu-
lar formation occurred. We have previously demonstrated
that the icp does not contribute to the Sp5-CN projection
(Zhou and Shore, 2004). Although the medullar reticular
formation does project to the CN (Shore and Zhou, 2006),
the region that contains the most CN projection neurons is
rostral to the Sp5I and Sp5C (pars caudalis). In the
present study, all injections were located in the interme-
diate to caudal part of Sp5I. In addition, the distribution,
morphology, and colocalization of the labeled terminal
endings with VGLUT-ir from these four animals were
similar to those from animals with restricted injections.
Therefore, contributions from lateral medulla reticular
formation to the terminal labeling in the CN were mini-
mal. Nonetheless, the quantification analysis was based
only on the two animals in which the injections were
restricted to the Sp5.
Colocalization of Sp5 endings with VGLUT2. The
most prominent Sp5 labeled terminals were large, irreg-
ular swellings (2 m), characteristic of MFs (Weedman
et al., 1996; Wright and Ryugo, 1996), in the GCD (Figs.
4A–F, 6A). Sp5 MFs that colabeled with VGLUT2 (47.7%
 3%, Figs. 4, 6C) were restricted to the GCD (Fig. 6B),
which receives the majority of Sp5 terminals (Zhou and
Shore, 2004). These endings did not show morphological or
topographical differences from those that did not colabel
with VGLUT2 (Fig. 4D–F). A lower percentage of the
small Sp5 boutons (2 m) located throughout the CN
colabeled with VGLUT2 (11.5%  0.5% in the GCD, and
12.1%  8% in the VCN; Figs. 4G–L, 6B). No colocaliza-
tion of Sp5 boutons with VGLUT2-ir was evident in DCN1
and DCN3 (Fig. 6B).
Lack of colocalization of Sp5 endings with VGLUT1.
In strong contrast, the majority of labeled Sp5 terminals,
including MFs and small boutons, did not colocalize with
VGLUT1-ir (Figs. 5, 6). Few Sp5 MFs (2.5%  1%) cola-
beled with VGLUT1, significantly fewer than were cola-
beled with VGLUT2 (47.7%  3%; paired t-test, P  0.05).
These VGLUT1-labeled Sp5 MFs did not show morpholog-
ical or topographical differences from those that did not
colabel with VGLUT1 or VGLUT2. No small Sp5 boutons
colabeled with VGLUT1. The paucity of colocalization of
Sp5 terminals with VGLUT1-ir was evident in all CN
subdivisions, even in the DCN1 that showed intense
VGLUT1 expression (Fig. 5C). Only 2%  0.1% of total
Sp5 terminal endings (both MFs and small boutons) cola-
beled with VGLUT1, significantly fewer than colabeled
with VGLUT2 (23.6% 1%; paired t-test, P  0.05).
ANF terminals colabel with VGLUT1
Infusion of FG into the labyrinth resulted in heavy
labeling of ANFs and their terminals in the VCNm and
the DCN3, but only a few labeled axons entered the shell
region. The most prominent ANF terminal endings in the
CN were the endbulb-like endings in the VCNm (Fig. 7).
In addition, large numbers of bead-like terminal boutons
were evident in the VCNm and the DCN3. Most labeled
ANF endbulb-like terminals (Fig. 6D; 79.5%  7%) colo-
calized with VGLUT1 in VCNm (Fig. 7A, arrows). Many
bead-like ANF terminals or small boutons were also la-
beled with VGLUT1 in VCNm (Fig. 7A, arrowheads;
43.0%  3%; see also Fig. 6D) and DCN3 (Fig. 7B, arrow-
heads; 26.0%  5%; see also Fig. 6D). These small ANF
boutons that were colabeled with VGLUT1 were not mor-
phologically or topographically different from those that
were not colabeled with VGLUT1. In contrast, neither
ANF endbulb-like terminals (0%; Fig. 6D) nor small bou-
tons (0%; Fig. 6D) was colocalized with VGLUT2 (Fig.
7C,D).
Fig. 4. High-magnification confocal images (63) showing colocal-
ization of anterogradely labeled Sp5 terminal endings with
VGLUT2-ir in different regions of the CN. Green, VGLUT-ir; red, Sp5
labeling; yellow, double-labeled terminals. A–F were obtained from Z
projections of stacks of serial 1-m confocal images and G–L each
show a single, 1-m confocal image. Insets in A–F show a single 1-m
confocal image. A–F: MFs are labeled with BDA from Sp5 and
VGLUT2 in the shell. Colocalization of Sp5 MFs with VGLUT2-ir is
indicated by arrowheads in C,F. G–I: Small boutons are labeled with
BDA from Sp5 and VGLUT2 in DCN2. Colocalization of Sp5 small
boutons with VGLUT2 is shown by arrows in I. J–L: Small boutons
are labeled with BDA from Sp5 and VGLUT2 in VCNm. Colocaliza-
tion of Sp5 small boutons with VGLUT2-ir is shown by arrows in L.
Scale bar  10 m.
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DISCUSSION
This work confirms previous findings that VGLUT expres-
sion in the CN is differentially distributed according to re-
gion (Herzog et al., 2001; Kaneko et al., 2002). We extend
these findings by demonstrating that the differential distri-
butions of VGLUT1 and VGLUT2 are associated with differ-
ent sources of afferent inputs to the CN: Sp5 projections
were colocalized with VGLUT2, whereas VIIIth nerve pro-
jections to the CN were colocalized with VGLUT1.
VGLUT expression in the CN is associated
with different sources of afferent input
The most intense VGLUT1-ir was seen in the VCNm
and DCN1, whereas the most intense expression of
VGLUT2 was in the GCD. These CN subdivisions are
associated with different sources of afferent inputs: The
GCD, encompassing the shell region and DCN2, receives
projections from variety of nonauditory sources, including
the Sp5, the trigeminal ganglion, reticular formation and
the cuneate nucleus (Haenggeli et al., 2005; Li and Mi-
zuno, 1997; Ohlrogge et al., 2001; Shore et al., 2000; Weed-
man et al., 1996; Wright and Ryugo, 1996; Zhou and
Shore, 2004; Shore and Zhou, 2006). The magnocellular
regions of the CN, including both VCNm and DCN3, re-
ceive projections from type I ANFs (Brown and Ledwith,
1990; Fekete et al., 1984; Liberman, 1993; Shore and
Moore, 1998). The DCN1, the most superficial layer of
DCN, comprises predominantly parallel fiber inputs from
granule cells in the GCD. Thus, VGLUT1 and -2 may be
specifically associated with the synaptic transmission of
these different circuits.
The morphological appearances of VGLUT-ir puncta
also suggest circuit-specific associations. VGLUT2-ir
puncta in the GCD were mostly in the form of large,
irregular swellings that resemble MFs. The sources of MF
endings include several nonauditory structures, including
somatosensory systems and the reticular formation
(Haenggeli et al., 2005; Ohlrogge et al., 2001; Shore and
Zhou, 2006; Weedman et al., 1996; Wright and Ryugo,
1996; Zhou and Shore, 2004). As shown here, the Sp5
terminal endings in the CN are either small boutons or
large Mfs, which is consistent with previous studies
(Haenggeli et al., 2005; Ohlrogge et al., 2001; Wright and
Ryugo, 1996; Zhou and Shore, 2004).
In contrast, numerous endbulb-like VGLUT1 labeled
terminals from type I ANFs were seen around large cell
bodies in the VCNm, suggesting that the ANF glutama-
tergic projection to CN is mediated by VGLUT1. The in-
tense, small granular labeling of VGLUT1 in the DCN1
indicates that VGLUT1 is associated with intrinsic con-
nections within the CN, i.e., the parallel fiber-to-DCN
projection. This is consistent with the findings that paral-
lel fiber terminals in the cerebellar cortex use VGLUT1 for
accumulation of glutamate into the synaptic vesicles
(Fremeau et al., 2004a; Kaneko et al., 2002).
VGLUT2 mediates glutamate transport at
Sp5 terminals
The colocalization of VGLUT2-ir with Sp5 terminals
demonstrated here indicates that 1) the Sp5 pathway to
the CN is glutamatergic and 2) Sp5 projections to CN use
VGLUT2 to mediate glutamate transport at both their
MF- and small bouton terminal endings. MF terminals in
the CN resemble those in the cerebellar cortex. They are
located predominantly in the GCD and make synaptic
connections with the dendric claws of granule cells (Weed-
man et al., 1996). Sp5 small boutons, which are more
numerous than Sp5 MFs, probably make contacts with
cells other than granule cells (Haenggeli et al., 2005; Zhou
and Shore, 2004), as observed for bouton terminals from
other nonauditory projections to the CN, including those
from the cuneate and pontine nuclei (Ohlrogge et al., 2001;
Wright and Ryugo, 1996). MFs give rise to collaterals
(Haenggeli et al., 2005; Wright and Ryugo, 1996; Zhou and
Shore, 2004), so it is likely that small bouton terminals
arise not only directly from the Sp5 but also as collaterals
from MFs.
Sp5 projections to CN convey somatosensory informa-
tion pertaining to head and neck position and vocal tract
gestures to the CN and can modify the output of DCN
projection neurons via the MF-granule cell-fusiform cell
circuit. This circuit provides information relating to head
Fig. 5. Sp5 terminal endings do not colabel with VGLUT1. High-
magnification confocal images (63) of Sp5 terminal endings and
VGLUT1-ir in different regions of the CN. Green, VGLUT-ir; red, Sp5
labeling; yellow, double-labeled terminals. All figures show a single,
1-m confocal image. A: Sp5 MFs (arrowhead) and small boutons
(arrow) did not colabel with VGLUT1 in the shell. B: Sp5 small
boutons did not colabel with VGLUT1 in VCNm. C: Sp5 small boutons
did not colabel with VGLUT1 in DCN1. Scale bar  10 m.
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or neck position to facilitate sound localization (Davis et
al., 1996; Kanold and Young, 2001; Young et al., 1995). It
may also act as an “adaptive filter” to cancel out internal
noise (such as chewing, self-vocalization, and respiration),
as suggested by the observation that stimulation of the
trigeminal nerve can suppress the DCN responses elicited
by sound (Shore, 2005). It may serve to improve signal-to-
noise ratios when attention is directed to a particular
location (Oertel and Young, 2004; Shore, 2005).
VGLUT1 mediates glutamate transport at
ANF terminals
Consistently with previous studies (Brown and Led-
with, 1990; Fekete et al., 1984; Shore and Moore, 1998),
the present study demonstrated that infusion of FG into
the labyrinth resulted in heavy labeling of eighth nerve
axons and their terminals in the VCNm and DCN3. Large,
endbulb-like ANF terminals endings surrounded large so-
mata in VCNm. Small ANF boutons were located in the
neuropil of both the VCNm and the DCN3.
The ANF endbulb synapse onto bushy cells provides a
secure synaptic connection with the postsynaptic neurons
and allows the relay of precise acoustic information. Co-
localization of VGLUT1-ir with the FG-labeled AN end-
ings around the somata of large neurons, as well as with
small boutons in the neuropil, indicates that VGLUT1
mediates glutamate transport for the bushy cells as well
as other cells that receive bouton-type endings on their
dendrites, such as stellate or octopus cells (Fekete et al.,
1984; Liberman, 1993; Tolbert and Morest, 1982). Small
numbers of FG-labeled ANFs were observed in the shell
region. These endings were thin (1 m), formed small en
passant or terminal boutons, and were likely to be type II
ANFs (Benson and Brown, 2004; Brown and Ledwith,
1990). These thin ANFs did not colocalize with either
VGLUT1-ir or VGLUT2-ir. This finding is consistent with
previous observations that glutaminase-like immunoreac-
tivity is not seen in type II spiral ganglion cells (Altschuler
et al., 1984), suggesting that a neurotransmitter other
than glutamate is used by these cells.
Possible roles of VGLUTs in the Sp5 and
ANF terminals
The slight structural difference between VGLUT1 and
VGLUT2 may lead to different interactions with other
proteins and, in turn, affect the vesicle filling and recy-
cling of VGLUT isoforms at the nerve terminal (Fremeau
et al., 2004b; Herzog et al., 2001). The finding that
VGLUT1 mediates glutamate transport of the presumed
Fig. 6. Counts of labeled Sp5 terminal endings colocalized with
VGLUT1-ir and VGLUT2-ir in different subdivisions of the CN (n 
2). About 50% of MFs and 12% of small Sp5 boutons colabeled with
VGLUT2. Significantly fewer (2.5%  1%) Sp5 MFs colabeled with
VGLUT1 (paired t-test, P  0.05), and no small Sp5 boutons colabeled
with VGLUT1; 23.6%  1% of total Sp5 terminal endings (both MFs
and small boutons) colabeled with VGLUT2, which is significantly
greater than the endings colabeled with VGLUT1 (2%  0.1%; paired
t-test, P  0.05). In contrast, many labeled ANFs (79.5%  7% of
endbulb-like terminals and 43.0%  3% of bead-like terminals) colo-
calized with VGLUT1 in the VCNm as well as in the DCN3 (26.0% 
5%). Neither ANF endbulb-like terminals nor small boutons was
colocalized with VGLUT2. Error bars represent SEM. Asterisks indi-
cate significant differences (see text). M, MFs; B, boutons; T, total
(MFs and boutons); E, endbulb-like terminals.
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type I ANFs in the CN suggests that VGLUT1 is likely
involved in conveying the precise temporal information
available in the acoustic signal. High temporal precision,
for which fast packaging and recycling of glutamate is
required, is accomplished by calyceal terminals in several
major ascending pathways, including CN and superior
olive complex (SOC). Strong VGLUT1 expression in the
calyceal terminals in the SOC supports the concept that
VGLUT1 is involved in conveying precise timing (Blaesse
et al., 2005). However, it remains unclear whether the
VGLUT1 in the presumed parallel fibers in the DCN1 is
also associated with fast transmission.
In contrast to the rapid transmission of information
between ANFs and magnocellular neurons in the CN, the
transfer of information from the somatosensory system to
the CN is likely to be either more modulatory or slower in
Fig. 7. High-magnification, 1-m confocal images (63) showing
colocalization of AN terminal endings with VGLUT1-ir, but not
VGLUT2-ir, in both VCNm and DCN3. Green, VGLUT-ir; red, FG
filled AN fibers and endings; yellow, double-labeled terminals. All
figures show a single, 1-m confocal image. A,B: Colocalization of AN
terminal endings with VGLUT1-ir in VCNm (A) and DCN3 (B). Both
endbulb-like AN endings (arrows in A) and small boutons (arrow-
heads in A,B) colabeled with the VGLUT1. C,D: VGLUT2 did not
label the AN endings in both VCNm (C) and DCN3 (D). Scale bars 
20 m.
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nature. In the cerebellum, MFs are able to adjust synaptic
strength via enhanced neurotransmitter release (Sola et
al., 2004). Such a role in synaptic plasticity might also be
expected in the DCN, with its cerebellar-like organization
(Tzounopoulos et al., 2004). VGLUT2, which mediates glu-
tamate transport of Sp5 MF endings, might therefore be
associated with DCN synaptic plasticity.
The difference in recycling of the two isoforms at the
nerve terminals has been previously demonstrated. In the
stratum radiatum of the VGLUT1 knockout mouse, repet-
itive stimulation led to more rapid short-term depression
with a slower recovery than in wild-type mice, suggesting
that VGLUT2 is responsible for this plasticity. Thus,
VGLUT1- and VGLUT2-mediated synapses originating
from the same neuron may exhibit different forms of synap-
tic transmission. Clearly, more physiological evidence is
needed to elucidate the functional significance of VGLUT
isoforms in synaptic transmission (Fremeau et al., 2004a).
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